Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-06-01
著者
-
ICHIKAWA Wataru
Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
-
SASAKI Yasutsuna
Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
-
Sasaki Yasutsuna
Department Of Clinical Oncology And Medical Oncology International Medical Center Saitama Medical Un
-
Ichikawa Wataru
Department Of Medical Oncology Comprehensive Cancer Center Saitama Medical University
-
ICHIKAWA Wataru
Department of Clinical Oncology and Medical Oncology, International Medical Center, Saitama Medical University
関連論文
- Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)(Miscellaneo
- CYP2A6 and the plasma level of 5-chloro-2,4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
- Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer
- Novel Single Nucleotide Polymorphism of UGT1A9 Gene in Japanese
- Novel Single Nucleotide Polymorphism of UGT1A7 Gene in Japanese
- Acute gefitinib-induced pneumonitis
- Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1^*28 and/or UGT1A1^*6 polymorphisms
- Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer